|
|
Welcome to Next Generation Pain Treatment |
|
Based on a novel product class, SantoSolve is developing a new generation of analgesic agents to create a safer and better future for pain patients.
Latest news:
November 17 2009 - SantoSolve completes patient enrollment in first pivotal phase III trial in osteoarthritis Read more...
October 26, 2009 - SantoSolve AS raises USD 5.5 million
Read more... |
|
|
|
